Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...

Fatigue is a common problem for people with psoriatic arthritis. According to the National Psoriasis Foundation, some studies indicate that half of all psoriatic arthritis patients have ...

Psoriatic arthritis surgery could involve removing damaged tissue or bone or replacing a joint with severe damage. Learn more ...

FDA Approvals, May 02, 2022 Hypocaloric Diet Controls Joint Activity in Psoriatic Arthritis A 12-week hypocaloric diet provided suitable control of joint disease activity in patients with ...

The FDA has approved a label extension for Johnson & Johnson’s Tremfya (guselkumab) in psoriatic arthritis, the first drug from the IL-23 class to gain a foothold in this indication.

UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...

In some cases, it can lead to psoriatic arthritis (PsA), which affects the joints. A person with PsA may have swollen, inflamed joints, reduced movement, fatigue, and nail changes. Many people ...

Symptoms of psoriatic arthritis are similar to rheumatoid arthritis and include, pain, swelling and stiffness in one or more ...

Achieving remission may improve these outcomes. Natural history of psoriatic arthritis There are inconsistencies in the literature about the natural history of the condition, which may reflect ...

Essentially, he was asking what makes RA different from the type of arthritis that you usually hear about: osteoarthritis.